Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease

Journal of Pathology

Volumn 186, Issue 4, 1998, Pages 416-421

  Dijkstra, Gerard ^a   Moshage, Han ^a   Van Dullemen, Hendrik M ^a   De Jager Krikken, Alie ^a   Tiebosch, Anton T M G ^a   Kleibeuker, Jan H ^a   Jansen, Peter L M ^a   Van Goor, Harry ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Inflammatory bowel disease; Nitric oxide; Nitric oxide synthase; Nitrotyrosine; Reactive oxygen species

Indexed keywords

3 NITROTYROSINE; NITRIC OXIDE SYNTHASE; OXYGEN RADICAL;

ADULT; ARTICLE; CELL DAMAGE; CLINICAL ARTICLE; COLON CROHN DISEASE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME LOCALIZATION; FEMALE; HUMAN; MALE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TISSUE DISTRIBUTION; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN SPECIES; TYROSINE;

EID: 0032415840     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199812)186:4<416::AID-PATH201>3.0.CO;2-U     Document Type: Article

References (31)

1. Lih-Brody L, Powell SR, Collier KP, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996; 41: 2078-2086.
2. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
3. Farrell AJ, Blake DR. Nitric oxide. Ann Rheum Dis 1996; 55: 7-20.
4. Barnes PJ, Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071.
5. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043-10047.
6. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283-286.
7. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271: C1424-C1437.
8. Oudkerk Pool M, Bouma G, Visser JJ, et al. Serum nitrate levels in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 1995; 30: 784-788.
9. Sasajima K, Yoshida Y, Yamakado S, et al. Changes in urinary nitrate and nitrite during treatment of ulcerative colitis. Digestion 1996; 57: 170-173.
10. Middleton SJ, Shorthouse M, Hunter JO. Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993; 341: 465-466.
11. Reynolds PD, Middleton SJ, Hansford GM, Hunter JO. Confirmation of nitric oxide synthesis in active ulcerative colitis by infra-red diode laser spectroscopy. Eur J Gastroenterol Hepatol 1997; 9: 463-466.
12. Boughton Smith NK, Evans SM, Hawkey CJ, et al. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993; 342: 338-340.
13. Kimura H, Miura S, Shigematsu T, et al. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci 1997; 42: 1047-1054.
14. Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolosky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995; 36: 718-723.
15. Van Deventer SJ. Tumour necrosis factor and Crohn's disease. Gut 1997; 40: 443-448.
16. van Hogezand RA, Verspaget HW. New therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapy. Scand J Gastroenterol Suppl 1997; 32: 105-107.
17. Neurath MF, Petterson S, Meyer zum Buschenfelde KH, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-KB abrogates established experimental colitis in mice. Nature Med 1997; 2: 998-1004.
18. Dobosz M, Mionskowska L, Dobrowolski S, et al. Is nitric oxide and heparin treatment justified in inflammatory bowel disease? An experimental study. Scand J Clin Lab Invest 1996; 56: 657-663.
19. Pfeifler CJ, Qiu BS. Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats. J Pharm Pharmacol 1995; 47: 827-832.
20. McCafferty DM, Mudgett JS, Swain MG, Kubes P. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 1997; 112: 1022-1027.
21. Beckman JS, Ye YZ, Anderson P, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 1994; 375: 81-88.
22. Briggs RT, Robinson JM, Karnovsky ML, Karnovsky MJ. Superoxide production by polymorphonuclear leukocytes. A cytochemical approach. Histochemistry 1986; 84: 371-378.
23. Singer II, Kawka DW, Scott S, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996; 111: 871-885.
24. Miapamba M, Sharkey KA. Distribution of inducible nitric oxide synthase and nitrotyrosine in the rat colon in experimental colitis. Gastroenterology 1997; 112: A1041.
25. Burgio VL, Fais S, Boirivant M, Perrone A, Pallone F. Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 1995; 109: 1029-1038.
26. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705-4708.
27. McLaughlan JM, Seth R, Vautier G, et al. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol 1997; 181: 87-92.
28. Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 1996; 270: G225-237.
29. Rachmilewitz D, Karmeli F, Okon E, Bursztyn M. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 1995; 37: 247-255.
30. Gaginell TS, Kachur JF, Tamai U, Keshavarizian A. Reactive oxygen and nitrogen metabolites as mediators of secretory diarrhoea. Gastroenterology 1995; 109: 2019-2028.
31. Ribbons KA, Currie MG, Connor JR, et al. The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. J Pharmacol Exp Ther 1997; 280: 1008-1015.